4,386 -- company count for Life science and pharma construction, general contractor and development firms (2025)

The company count for Life science and pharma construction, general contractor and development firms is 4,386 as of 2025 according to Biscred. This figure is the primary benchmark in the Lighthouse dataset for this segment. Individual results vary by region, channel mix, and audience quality.

A strong company count benchmark for Life science and pharma construction, general contractor and development firms is 4,386, using the current serving value as of 2025. This is one serving-eligible observation, not a distribution median; top-quartile comparisons require the underlying distribution. Vertical, audience size, and campaign type all shift what 'good' means.

The published company count serving value for Life science and pharma construction, general contractor and development firms is 4,386 as of 2025. Individual sectors and audiences may differ substantially; this single observation does not establish an aggregate mean. Quartile comparisons require the underlying distribution, which is not implied by this record.

Primary drivers of company count variation for Life science and pharma construction, general contractor and development firms include audience segmentation, timing, and channel selection. Methodology documents campaign factors, but this serving record does not quantify the effect of personalization. The current serving value is 4,386 as of 2025.

For a digital marketer, the published company count serving value is 4,386; it is an evidence-grade reference, not a personalized target as of 2025. Any performance goal should account for channel mix and audience. Review the methodology before operational decisions; a gap from this serving value does not by itself indicate a structural issue.